Kimberly Blackwell Net Worth & Insider Trades
Kimberly Blackwell - Chief Executive Officer, Zentalis Pharmaceuticals, Inc
What is Kimberly Blackwell's Net Worth?
The current estimated net worth of Zentalis Pharmaceuticals, Inc's Chief Executive Officer, Kimberly Blackwell, is estimated to be about $451.58K . Kimberly Blackwell owns about 254,800 units of Zentalis Pharmaceuticals, Inc common stock. In the last 3 years at Zentalis Pharmaceuticals, Inc, Kimberly Blackwell has sold an estimated value of $323.63K worth.
What is Kimberly Blackwell's Past Insider Trading?
Kimberly Blackwell's largest purchase order was 5,000 units , worth over $51.45K on November 13, 2023. Kimberly Blackwell's largest sale order was 1,000 units , worth over $83.74K on January 5, 2022. In total, Kimberly Blackwell has made about 9 transactions over 3 years of their time at Zentalis Pharmaceuticals, Inc. Kimberly Blackwell usually trades in November, with the busiest year in 2021.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Kimberly Blackwell
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Kimberly Blackwell's' Mailing Address?
- Mailing address is C/o Zentalis Pharmaceuticals, Llc 530 Seventh Avenue, Suite 2201 New York NY 10018 NY
Zentalis Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Anthony Sun, M.D. | 2020 | $561,232 | - | $8,100,645 | $5,986,469 | $287,375 | $108,678 | $15,044,399 |
| Anthony Sun, M.D. | 2019 | $455,091 | - | - | $918,000 | $204,971 | - | $1,577,882 |
| Kevin Bunker, Ph.D. | 2020 | $428,771 | - | $2,580,864 | $2,993,235 | $179,550 | $91,174 | $6,273,594 |
| Kevin Bunker, Ph.D. | 2019 | $360,024 | - | - | $275,400 | $144,010 | - | $779,434 |
| Alexis M. Pinto | 2020 | $136,923 | - | - | $6,234,468 | $152,000 | $10,511 | $6,533,902 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1725160/000172516021000099/proxystatement-2021.htm
What are Zentalis Pharmaceuticals, Inc's Past Insider Trades?
Zentalis Pharmaceuticals, Inc's most recent insider trade came on November 13, 2023 by David M. Johnson who bought 17,000 units worth $167.94K . In the last 3 years, insiders at Zentalis Pharmaceuticals, Inc have sold an estimated value of $111.75M and bought an estimated value of $123.85M worth of shares. Insider trading is most common in February, with the busiest year in 2021. The most active traders at the company are Cam Gallagher, President, Kevin D Bunker, Chief Scientific Officer, and Anthony ySun, President & CEO .
Zentalis Pharmaceuticals, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||